ID: ALA3276827

Max Phase: Preclinical

Molecular Formula: C15H15N3O

Molecular Weight: 253.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1ccc(N2CCNC(=O)c3ccccc32)cc1

Standard InChI:  InChI=1S/C15H15N3O/c16-11-5-7-12(8-6-11)18-10-9-17-15(19)13-3-1-2-4-14(13)18/h1-8H,9-10,16H2,(H,17,19)

Standard InChI Key:  FYPNDPFRSQSHAX-UHFFFAOYSA-N

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ileum 856 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 253.31Molecular Weight (Monoisotopic): 253.1215AlogP: 2.15#Rotatable Bonds: 1
Polar Surface Area: 58.36Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.12CX LogP: 1.71CX LogD: 1.71
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.77Np Likeness Score: -0.63

References

1. Bagolini C, de Witt P, Pacifici L, Ramacci MT..  (1978)  Synthesis and pharmacological activity and some derivatives of 1-phenyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one.,  21  (5): [PMID:26804] [10.1021/jm00203a015]

Source